Vogelxo

Orchitis, Puberty, Delayed, Gonadotrophin releasing hormone deficiency + 9 more
Treatment
17 FDA approvals
5 Active Studies for Vogelxo

What is Vogelxo

TestosteroneThe Generic name of this drug
Treatment SummaryTestosterone is a hormone used to treat conditions where the body does not produce enough of the hormone naturally. It works by blocking the androgen receptor, which helps produce the male sex organs and other male sexual characteristics. Testosterone was first isolated from a sample in 1935 and then synthesized.
Androdermis the brand name
Vogelxo Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Androderm
Testosterone
1995
90

Approved as Treatment by the FDA

Testosterone, commonly known as Androderm, is approved by the FDA for 17 uses including Spermatic Cord Torsion and Puberty, Delayed .
Spermatic Cord Torsion
Helps manage Torsion of testis
Puberty, Delayed
Used to treat Puberty, Delayed in combination with Testosterone enanthate
Orchitis
Helps manage Orchitis
Orchitis
Helps manage Orchitis
Hypergonadotropic Hypogonadism
Helps manage Hypergonadotropic Hypogonadism
Hypogonadism
Helps manage Hypergonadotropic Hypogonadism
Breast
Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate
Torsion of testis
Helps manage Torsion of testis
Hypothalamo-pituitary disorder
Helps manage Hypothalamo-pituitary disorder
Hypogonadotropic hypogonadism
Delayed Puberty
Used to treat Puberty, Delayed in combination with Testosterone enanthate
Gonadotrophin releasing hormone deficiency
Helps manage Gonadotrophin releasing hormone deficiency
1 to 5 years post-menopausal
Used to treat 1 to 5 years post-menopausal in combination with Testosterone enanthate
vanishing testis syndrome
Helps manage vanishing testis syndrome
Orchidectomy
Helps manage Orchidectomy
inoperable, metastatic Breast cancer
Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate
Hypogonadism
Helps manage Idiopathic Hypogonadotropic Hypogonadism

Effectiveness

How Vogelxo Affects PatientsTestosterone helps to form the sex organs and characteristics that are typically seen in men. How long it stays in the body can vary from person to person, with a typical half-life of 10-100 minutes. The amount of testosterone in an adult man's body usually ranges from 300-1000ng/dL, making it a relatively safe drug. It is important to caution patients about the potential for children to be exposed to testosterone when using topical products.
How Vogelxo works in the bodyThe androgen receptor is a protein that is found in the cytoplasm and binds to molecules like testosterone and dihydrotestosterone. Once bound, the androgen receptor changes shape and is transported to the nucleus. This allows it to bind to DNA and cause certain genes to be expressed. Testosterone and dihydrotestosterone are responsible for the formation of male sex organs, as well as secondary physical characteristics like facial and body hair, a deeper voice, and changes in muscle and fat distribution.

When to interrupt dosage

The quantity of Vogelxo is reliant upon the diagnosed disorder, like Gonadotrophin releasing hormone deficiency, Orchidectomy and Orchitis. The degree of dosage is contingent on the technique of delivery specified in the table beneath.
Condition
Dosage
Administration
1 to 5 years post-menopausal
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
vanishing testis syndrome
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Spermatic Cord Torsion
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Gonadotrophin releasing hormone deficiency
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Hypothalamo-pituitary disorder
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Orchidectomy
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Hypogonadism
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Orchitis
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Puberty, Delayed
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Breast
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Hypogonadism
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral
Hypogonadotropic hypogonadism
, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg
, Transdermal, Gel, Gel - Transdermal, Intramuscular, Injection, solution - Intramuscular, Injection - Intramuscular, Topical, Gel - Topical, Subcutaneous, Pellet, Pellet - Subcutaneous, Patch, Patch - Transdermal, Solution, Solution - Topical, Buccal, Tablet, Tablet - Buccal, Oral, Pellet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Intramuscular, Nasal, Gel - Nasal, Gel, metered, Gel, metered - Topical, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable, Pellet, implantable - Subcutaneous, Parenteral, Pellet, implantable - Parenteral

Warnings

Vogelxo has two contraindications and should not be taken for the conditions illustrated in the following table.Vogelxo Contraindications
Condition
Risk Level
Notes
suspected pregnancy
Do Not Combine
Breast Cancer
Do Not Combine
There are 20 known major drug interactions with Vogelxo.
Common Vogelxo Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Testosterone.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Testosterone.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Testosterone.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Testosterone.
Astemizole
Major
The metabolism of Astemizole can be increased when combined with Testosterone.
Vogelxo Toxicity & Overdose RiskThere is limited information available on the effects of a testosterone product overdose. If an injectable product is overdosed on, the patient may suffer a stroke. Treatment for testosterone overdoses should involve ceasing the product, washing off any topical products, and providing supportive care.

Vogelxo Novel Uses: Which Conditions Have a Clinical Trial Featuring Vogelxo?

Ten active studies are examining the efficacy of Vogelxo in providing relief from Orchitis, Testicular Torsion and Hypothalamo-pituitary Dysfunctions.
Condition
Clinical Trials
Trial Phases
Hypothalamo-pituitary disorder
0 Actively Recruiting
1 to 5 years post-menopausal
0 Actively Recruiting
Hypogonadism
0 Actively Recruiting
Orchitis
0 Actively Recruiting
Spermatic Cord Torsion
0 Actively Recruiting
Breast
0 Actively Recruiting
Orchidectomy
0 Actively Recruiting
Hypogonadotropic hypogonadism
0 Actively Recruiting
Puberty, Delayed
0 Actively Recruiting
Gonadotrophin releasing hormone deficiency
0 Actively Recruiting
vanishing testis syndrome
0 Actively Recruiting
Hypogonadism
5 Actively Recruiting
Phase 4, Phase 2, Phase 1

Vogelxo Reviews: What are patients saying about Vogelxo?

2.7Patient Review
9/18/2017
Vogelxo for Deficiency of a Substance that Promotes Masculinization
I had a lot of deep pimples while using this medication. They were below the surface of my skin and really hurt. The cream was also tacky and made my skin feel uncomfortable. I only gave it one star because I shouldn't have had a painful rash.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about vogelxo

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Vogelxo generic?

"No generic form of this product exists. Counterfeit versions of the drug sold by fraudulent online pharmacies may be unsafe."

Answered by AI

How many doses in testosterone pump?

"The recommended dose for Vogelxo is 50 mg applied to clean, dry skin once a day. Your doctor may adjust your dose as needed, but the maximum recommended dose is 100 mg once a day."

Answered by AI

How many grams of testosterone per pump?

"A metered-dose pump that delivers 20.25 mg of testosterone in 1.25 g of gel with each pump actuation."

Answered by AI

Is Vogelxo a controlled substance?

"Under the Act, it is unlawful to knowingly or intentionally manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance.

Vogelxo contains testosterone, a substance that is regulated under the Controlled Substances Act. It is against the law to knowingly produce, distribute, or dispense this substance, or to possess it with the intent to do so."

Answered by AI

Clinical Trials for Vogelxo

Have you considered Vogelxo clinical trials? We made a collection of clinical trials featuring Vogelxo, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top